Michael Porter’s Five Forces model is a strategic framework used to analyze the competitive environment of the Australian LASIK eye surgery market. Business managers and investors seeking to gain a competitive advantage in this sector can apply this model to better understand the key factors influencing profitability, industry attractiveness, and long-term sustainability. Each of the five forces below has been analyzed in the context of the Australian LASIK market.
PORTER'S FIVE FORCES Analysis: Australia LASIK eye surgery market
Threat of New Entrants
The threat of new entrants in the Australian LASIK eye surgery market is moderate. While the initial capital investment for advanced laser technology and clinic setup is substantial, the rising demand for vision correction procedures makes the market appealing to new players. Established providers have built strong brand reputations and patient trust over years of operation, making it difficult for new entrants to gain immediate market share. However, increasing adoption of innovative technologies, telehealth consultations, and flexible financing options could encourage new clinics and optical chains to enter the market.
BARGAINING POWER OF SUPPLIERS
The bargaining power of suppliers in the Australian LASIK eye surgery market is moderate to high. Suppliers include manufacturers of laser systems, diagnostic tools, and surgical consumables that are critical to performing LASIK procedures. Because these technologies require precision and regulatory approval, there are relatively few global suppliers dominating the market, such as Alcon, Johnson & Johnson Vision, and Carl Zeiss Meditec. This limited supplier base gives them substantial leverage in pricing and contract negotiations. However, as the market expands and more distributors enter the Australian market, competition among suppliers may gradually reduce their power.
Threat of Substitutes
The threat of substitutes in the Australian LASIK market is moderate. Although LASIK provides long-term vision correction, several alternative treatments compete for the same patient base. Procedures such as PRK (Photorefractive Keratectomy), SMILE (Small Incision Lenticule Extraction), implantable contact lenses (ICLs), and orthokeratology offer different advantages based on individual eye conditions and preferences. Additionally, improvements in lens technology and reduced costs of premium eyewear maintain steady competition for LASIK. Despite these substitutes, the increasing desire for permanent and maintenance-free vision correction sustains LASIK’s appeal.
Bargaining Power of Buyers
The bargaining power of buyers in the Australian LASIK eye surgery market is high. Patients today are more informed, price-sensitive, and quality-conscious due to easy access to online reviews, testimonials, and clinic comparison platforms. As multiple clinics offer similar services, patients can negotiate pricing, demand financing options, or switch providers based on perceived value. Clinics also compete by offering promotional discounts and interest-free payment plans to attract patients. Furthermore, as LASIK is considered an elective procedure not typically covered by insurance, patients’ decisions are heavily influenced by affordability and trust.
Intensity of Rivalry
The intensity of rivalry in the Australian LASIK eye surgery market is high. The market features several well-established players, including specialized ophthalmic centers, large optical chains, and independent clinics, all competing to attract a growing but still niche segment of patients seeking refractive surgery. Differentiation is primarily achieved through technology (e.g., bladeless or wavefront-guided LASIK), surgeon expertise, customer experience, and financing flexibility. High marketing expenditure, including online advertising and patient education campaigns, further intensifies competition. Partnerships between ophthalmologists and optical retail brands are also becoming common to expand market reach.
Case Study Analysis
A 32-year-old Australian woman, referred to as “Marilyn,” underwent LASIK surgery nine years earlier to correct moderate myopia ranging from –6.00 to –7.00 diopters. Over time, she began experiencing regression of myopia in both eyes and presented for a clinical review. Her refraction measured –1.75/–0.50 × 015 in the right eye and –2.25/–0.25 × 150 in the left eye, with uncorrected vision of 6/4.5 in each eye. Ocular examination revealed a well-healed post-LASIK cornea with no signs of ectasia or scarring, and corneal topography displayed a large central flattening zone surrounded by peripheral steepening, an oblate corneal shape commonly seen after myopic LASIK. Rather than opting for a LASIK enhancement or retreatment, the patient chose a non-surgical solution and was fitted with overnight orthokeratology (OK) lenses despite the altered corneal shape.
After one night of OK lens wear, her unaided vision improved to 6/9-2 in the right eye and 6/12-2 in the left, with binocular vision of 6/6-2. By one week, morning unaided acuity reached 6/7.5+ in the right eye and 6/7.5-2 in the left, achieving binocular 6/6+2, and refraction had nearly normalized. After 3–4 weeks, both eyes achieved unaided visual acuity of 6/6+2 with binocular vision at 6/4.5 and plano refraction. At the six-month review, the patient reported high satisfaction, maintaining good vision though with mild dryness and slight evening blur; refraction remained stable at around –0.25 in each eye.
This case illustrates that while LASIK is highly effective for correcting myopia, long-term regression can occur, especially in patients with higher degrees of initial myopia. It also highlights the adaptability of orthokeratology as a viable non-surgical corrective method for post-LASIK patients with residual refractive errors. Clinically, it underscores the importance of patient counselling regarding potential long-term vision changes after LASIK and the availability of alternative treatments. From a market perspective, such cases emphasize the growing need for post-LASIK care, the value of offering complementary services like orthokeratology, and the necessity for continuous technological and procedural innovation in the Australian LASIK eye surgery market.
Investment & Funding Scenarios
Investment and funding scenarios in the Australian LASIK eye surgery market reflect a growing trend of financial innovation and technological advancement within the broader ophthalmic sector. As laser eye surgery remains an elective and high-cost procedure, funding models are evolving to make it more accessible and to support continuous technological development.
For individual patients, various funding options exist, including self-funding, where patients pay out of pocket for procedures that typically cost between $2,500 and $3,500 per eye. Many clinics also offer payment plans and financing options, enabling patients to spread costs over several months or years, often through partnerships with medical finance providers offering low or zero-interest rates. Additionally, medical loans are becoming increasingly popular, with financial institutions in Australia providing tailored healthcare financing solutions that make elective vision correction procedures more attainable without relying on traditional credit.
On a larger scale, the ophthalmic and laser vision correction industry continues to attract substantial institutional and venture capital investment. For Instance, In June 2025, funding round of ForSight Robotics, an Israeli company pioneering robotic ophthalmic surgery technologies, which secured US$125 million (approximately AU$191 million) to accelerate the development of its ORYOM Platform. a groundbreaking robotic system designed for cataract and eye surgeries.
